P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway

Oncology Reports

Volumn 34, Issue 1, 2015, Pages 103-110

  Xia, Jiyi ^a   Yu, Xiaolan ^a   Tang, Li ^a   Li, Gang ^a   He, Tao ^a  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

AKT pathway; ATP; Breast cancer; Invasion; Migration; P2x7 receptor

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; COLLAGENASE 3; MESSENGER RNA; PROTEIN KINASE B; PURINERGIC P2X7 RECEPTOR; UVOMORULIN; CADHERIN; MMP13 PROTEIN, HUMAN; ONCOPROTEIN;

ARTICLE; BREAST CANCER CELL LINE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MMP 13 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; T47D CELL LINE; UPREGULATION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; BREAST TUMOR; CARCINOGENESIS; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION; TUMOR MICROENVIRONMENT;

ADENOSINE TRIPHOSPHATE; BREAST NEOPLASMS; CADHERINS; CARCINOGENESIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 13; NEOPLASM INVASIVENESS; ONCOGENE PROTEIN V-AKT; RECEPTORS, PURINERGIC P2X7; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84930015180     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.3979     Document Type: Article

References (30)

1. Burnstock G: Purinergic signalling: Pathophysiology and therapeutic potential. Keio J Med 62: 63-73, 2013.
2. Braganhol E, Wink MR, Lenz G and Battastini AM: Purinergic signaling in glioma progression. Adv Exp Med Biol 986: 81-102, 2013.
3. Burnstock G: Introduction: P2 receptors. Curr Top Med Chem 4: 793-803, 2004.
4. Solini A, Cuccato S, Ferrari D, Santini E, Gulinelli S, Callegari MG, Dardano A, Faviana P, Madec S, Di Virgilio F, et al: Increased P2X7 receptor expression and function in thyroid papillary cancer: A new potential marker of the disease? Endocrinology 149: 389-396, 2008.
5. Zhang XJ, Zheng GG, Ma XT, Yang YH, Li G, Rao Q, Nie K and Wu KF: Expression of P2X7 in human hematopoietic cell lines and leukemia patients. Leuk Res 28: 1313-1322, 2004.
6. Li X, Qi X, Zhou L, Catera D, Rote NS, Potashkin J, Abdul-Karim FW and Gorodeski GI: Decreased expression of P2X7 in endometrial epithelial pre-cancerous and cancer cells. Gynecol Oncol 106: 233-243, 2007.
7. Li X, Zhou L, Feng YH, Abdul-Karim FW and Gorodeski GI: The P2X7 receptor: A novel biomarker of uterine epithelial cancers. Cancer Epidemiol Biomarkers Prev 15: 1906-1913, 2006.
8. DeSantis C, Ma J, Bryan L and Jemal A: Breast cancer statistics, 2013. CA Cancer J Clin 64: 52-62, 2014.
9. Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell 144: 646-674, 2011.
10. Jelassi B, Chantôme A, Alcaraz-Pérez F, Baroja-Mazo A, Cayuela ML, Pelegrin P, Surprenant A and Roger S: P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness. Oncogene 30: 2108-2122, 2011.
11. Sun SH: Roles of P2X7 receptor in glial and neuroblastoma cells: The therapeutic potential of P2X7 receptor antagonists. Mol Neurobiol 41: 351-355, 2010.
12. Canel M, Serrels A, Frame MC and Brunton VG: E-cadherin-integrin crosstalk in cancer invasion and metastasis. J Cell Sci 126: 393-401, 2013.
13. Sheng S, Qiao M and Pardee AB: Metastasis and AKT activation. J Cell Physiol 218: 451-454, 2009.
14. Yang G, Zhang S, Zhang Y, Zhou Q, Peng S, Zhang T, Yang C, Zhu Z and Zhang F: The inhibitory effects of extracellular ATP on the growth of nasopharyngeal carcinoma cells via P2Y2 receptor and osteopontin. J Exp Clin Cancer Res 33: 53, 2014.
15. Li WH, Qiu Y, Zhang HQ, Liu Y, You JF, Tian XX and Fang WG: P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells. Br J Cancer 109: 1666-1675, 2013.
16. Shi K, Queiroz KC, Stap J, Richel DJ and Spek CA: Protease-activated receptor-2 induces migration of pancreatic cancer cells in an extracellular ATP-dependent manner. J Thromb Haemost 11: 1892-1902, 2013.
17. Gu LQ, Li FY, Zhao L, Liu Y, Chu Q, Zang XX, Liu JM, Ning G and Zhao YJ: Association of XIAP and P2X7 receptor expression with lymph node metastasis in papillary thyroid carcinoma. Endocrine 38: 276-282, 2010.
18. Kwon JH, Nam ES, Shin HS, Cho SJ, Park HR and Kwon MJ: P2X7 receptor expression in coexistence of papillary thyroid carcinoma with Hashimoto's thyroiditis. Korean J Pathol 48: 30-35, 2014.
19. Adinolfi E, Raffaghello L, Giuliani AL, Cavazzini L, Capece M, Chiozzi P, Bianchi G, Kroemer G, Pistoia V and Di Virgilio F: Expression of P2X7 receptor increases in vivo tumor growth. Cancer Res 72: 2957-2969, 2012.
20. Hattori F, Ohshima Y, Seki S, Tsukimoto M, Sato M, Takenouchi T, Suzuki A, Takai E, Kitani H, Harada H, et al: Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7. Eur J Pharmacol 695: 20-26, 2012.
21. Takai E, Tsukimoto M, Harada H and Kojima S: Autocrine signaling via release of ATP and activation of P2X7 receptor influences motile activity of human lung cancer cells. Purinergic Signal 10: 487-497, 2014.
22. Wang Y and Zhou BP: Epithelial-mesenchymal transition in breast cancer progression and metastasis. Chin J Cancer 30: 603-611, 2011.
23. 2+ signaling as a consequence of EGF-induced epithelial-mesenchymal transition in breast cancer cells. PLoS One 6: e23464, 2011.
24. Paredes J, Figueiredo J, Albergaria A, Oliveira P, Carvalho J, Ribeiro AS, Caldeira J, Costa AM, Simões-Correia J, Oliveira MJ, et al: Epithelial E- and P-cadherins: Role and clinical significance in cancer. Biochim Biophys Acta 1826: 297-311, 2012.
25. Morrison C, Mancini S, Cipollone J, Kappelhoff R, Roskelley C and Overall C: Microarray and proteomic analysis of breast cancer cell and osteoblast co-cultures: Role of osteoblast matrix metalloproteinase (MMP)-13 in bone metastasis. J Biol Chem 286: 34271-34285, 2011.
26. Pivetta E, Scapolan M, Pecolo M, Wassermann B, Abu-Rumeileh I, Balestreri L, Borsatti E, Tripodo C, Colombatti A and Spessotto P: MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases. Breast Cancer Res 13: R105, 2011.
27. Zhang Y, Gong LH, Zhang HQ, Du Q, You JF, Tian XX and Fang WG: Extracellular ATP enhances in vitro invasion of prostate cancer cells by activating Rho GTPase and upregulating MMPs expression. Cancer Lett 293: 189-197, 2010.
28. Vázquez-Cuevas FG, Martínez-Ramírez AS, Robles-Martínez L, Garay E, García-Carrancá A, Pérez-Montiel D, Castañeda-García C and Arellano RO: Paracrine stimulation of P2X7 receptor by ATP activates a proliferative pathway in ovarian carcinoma cells. J Cell Biochem 115: 1955-1966, 2014.
29. Bian S, Sun X, Bai A, Zhang C, Li L, Enjyoji K, Junger WG, Robson SC and Wu Y: P2X7 integrates PI3K/AKT and AMPK-PRAS40-mTOR signaling pathways to mediate tumor cell death. PLoS One 8: e60184, 2013.
30. Lauring J, Park BH and Wolff AC: The phosphoinositide-3-kinase-Akt-mTOR pathway as a therapeutic target in breast cancer. J Natl Compr Canc Netw 11: 670-678, 2013.